{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:31:04Z","timestamp":1792373464701,"version":"4.4.0"},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,27]],"date-time":"2011-12-27T00:00:00Z","timestamp":1324944000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001406","type":"journal-article","created":{"date-parts":[[2011,12,27]],"date-time":"2011-12-27T21:40:36Z","timestamp":1325022036000},"page":"e1406","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Single Dose Novel Salmonella Vaccine Enhances Resistance against Visceralizing L. major and L. donovani Infection in Susceptible BALB\/c Mice"],"prefix":"10.1371","volume":"5","author":[{"given":"Juliane","family":"Schroeder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmeeyah","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Aebischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,12,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis.","volume":"354","author":"BL Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"F Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref3","first-page":"277","article-title":"Leishmaniasis: drug resistance and natural products.","volume":"22","author":"T Polonio","year":"2008","journal-title":"Int J Mol Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","article-title":"Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of <italic>Leishmania donovani<\/italic>.","volume":"180","author":"R Lira","year":"1999","journal-title":"J Infect Dis"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"e818","DOI":"10.1371\/journal.pntd.0000818","article-title":"Cost-Effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent.","volume":"4","author":"F Meheus","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1473-3099(05)70296-6","article-title":"Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980\u20132004.","volume":"5","author":"PL Olliaro","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"ref7","first-page":"377","article-title":"Effectiveness of leishmanization in the control of cutaneous leishmaniasis.","volume":"76","author":"A Nadim","year":"1983","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"ref8","first-page":"423","article-title":"Leishmaniasis vaccine candidates for development: a global overview.","volume":"123","author":"A Khamesipour","year":"2006","journal-title":"Indian J Med Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","article-title":"Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis.","volume":"23","author":"A Khamesipour","year":"2005","journal-title":"Vaccine"},{"key":"ref10","first-page":"240","article-title":"Characterization of Leishmania isolated from unhealed lesions caused by leishmanization.","volume":"11","author":"SM Hosseini","year":"2005","journal-title":"East Mediterr Health J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1016\/j.vaccine.2009.05.084","article-title":"Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis.","volume":"27","author":"S Noazin","year":"2009","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0974-777X.62881","article-title":"Leishmaniasis Vaccine: Where are We Today?","volume":"2","author":"L Kedzierski","year":"2010","journal-title":"J Glob Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4161\/hv.5.5.7607","article-title":"Vaccines and vaccination strategies against human cutaneous leishmaniasis.","volume":"5","author":"I Okwor","year":"2009","journal-title":"Hum Vaccin"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1371\/journal.pntd.0000943","article-title":"Vaccines for the Leishmaniases: Proposals for a Research Agenda.","volume":"5","author":"CHN Costa","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nm933","article-title":"Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8<sup>+<\/sup> T-cell responses.","volume":"9","author":"S Stager","year":"2003","journal-title":"Nat Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1128\/IAI.00944-07","article-title":"Hybrid cell vaccination resolves <italic>Leishmania donovani<\/italic> infection by eliciting a strong CD8<sup>+<\/sup> cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.","volume":"75","author":"R Basu","year":"2007","journal-title":"Infect Immun"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1128\/IAI.61.9.3730-3738.1993","article-title":"Gamma interferon response in secondary <italic>Leishmania major<\/italic> infection: role of CD8<sup>+<\/sup> T cells.","volume":"61","author":"I Muller","year":"1993","journal-title":"Infect Immun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","article-title":"Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with <italic>Leishmania major<\/italic>.","volume":"186","author":"S Gurunathan","year":"1997","journal-title":"J Exp Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.meegid.2009.02.009","article-title":"Vaccine development against <italic>Trypanosoma cruzi<\/italic> and Leishmania species in the post-genomic era.","volume":"9","author":"E Dumonteil","year":"2009","journal-title":"Infect Genet Evol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","article-title":"Vaccines for leishmaniasis in the fore coming 25 years.","volume":"26","author":"CB Palatnik-de-Sousa","year":"2008","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis.","volume":"21","author":"RN Coler","year":"2005","journal-title":"Trends Parasitol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.vaccine.2005.12.012","article-title":"From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine <italic>Leishmania major<\/italic> infection.","volume":"24","author":"CB Stober","year":"2006","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1369-5274(00)00119-3","article-title":"Reverse vaccinology.","volume":"3","author":"R Rappuoli","year":"2000","journal-title":"Curr Opin Microbiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1074\/mcp.M700343-MCP200","article-title":"Transgenic, fluorescent <italic>Leishmania mexicana<\/italic> allow direct analysis of the proteome of intracellular amastigotes.","volume":"7","author":"D Paape","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.145.7.2281","article-title":"Oral <italic>Salmonella typhimurium<\/italic> (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis.","volume":"145","author":"DM Yang","year":"1990","journal-title":"J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/IAI.65.1.171-178.1997","article-title":"Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters.","volume":"65","author":"SJ McSorley","year":"1997","journal-title":"Infect Immun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1128\/IAI.72.8.4924-4928.2004","article-title":"DNA-<italic>Salmonella enterica<\/italic> serovar Typhimurium primer-booster vaccination biases towards T helper 1 responses and enhances protection against <italic>Leishmania major<\/italic> infection in mice.","volume":"72","author":"UG Lange","year":"2004","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.4049\/jimmunol.170.5.2734","article-title":"Concomitant induction of CD4<sup>+<\/sup> and CD8<sup>+<\/sup> T cell responses in volunteers immunized with <italic>Salmonella enterica<\/italic> serovar Typhi strain CVD 908-htrA.","volume":"170","author":"R Salerno-Goncalves","year":"2003","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/gut.2007.145839","article-title":"Correlation of T cell response and bacterial clearance in human volunteers challenged with <italic>Helicobacter pylori<\/italic> revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines.","volume":"57","author":"T Aebischer","year":"2008","journal-title":"Gut"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1574-695X.2000.tb01450.x","article-title":"Recombinant live Salmonella spp. for human vaccination against heterologous pathogens.","volume":"27","author":"D Bumann","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1128\/IAI.71.11.6320-6328.2003","article-title":"Autodisplay: efficacious surface exposure of antigenic UreA fragments from <italic>Helicobacter pylori<\/italic> in Salmonella vaccine strains.","volume":"71","author":"K Rizos","year":"2003","journal-title":"Infect Immun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1016\/j.vaccine.2009.08.106","article-title":"Recombinant outer membrane vesicles to augment antigen-specific live vaccine responses.","volume":"27","author":"J Schroeder","year":"2009","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1128\/IAI.67.10.5133-5141.1999","article-title":"Use of in vivo-regulated promoters to deliver antigens from attenuated <italic>Salmonella enterica<\/italic> var. Typhimurium.","volume":"67","author":"SJ Dunstan","year":"1999","journal-title":"Infect Immun"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0378-1119(96)00343-5","article-title":"Absence of periplasmic DsbA oxidoreductase facilitates export of cysteine-containing passenger proteins to the <italic>Escherichia coli<\/italic> cell surface via the Iga beta autotransporter pathway.","volume":"178","author":"J Jose","year":"1996","journal-title":"Gene"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1046\/j.1365-2958.2002.02821.x","article-title":"Examination of salmonella gene expression in an infected mammalian host using the green fluorescent protein and two-colour flow cytometry.","volume":"43","author":"D Bumann","year":"2002","journal-title":"Mol Microbiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s004410050799","article-title":"A simple assay for quantification of protein in tissue sections, cell cultures, and cell homogenates, and of protein immobilized on solid surfaces.","volume":"288","author":"A Dieckmann-Schuppert","year":"1997","journal-title":"Cell Tissue Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.4049\/jimmunol.126.4.1614","article-title":"Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.","volume":"126","author":"C Taswell","year":"1981","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.4049\/jimmunol.164.7.3681","article-title":"B cell-deficient mice are highly resistant to <italic>Leishmania donovani<\/italic> infection, but develop neutrophil-mediated tissue pathology.","volume":"164","author":"SC Smelt","year":"2000","journal-title":"J Immunol"},{"key":"ref39","article-title":"IRF-7 contributes to the control of <italic>Leishmania donovani<\/italic> in the mouse liver.","author":"L Beattie","year":"2010","journal-title":"Infect Immun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1128\/IAI.70.11.6499-6503.2002","article-title":"Multiparameter selection of <italic>Helicobacter pylori<\/italic> antigens identifies two novel antigens with high protective efficacy.","volume":"70","author":"N Sabarth","year":"2002","journal-title":"Infect Immun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/513439","article-title":"HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by <italic>Leishmania donovani<\/italic>-infected human macrophages.","volume":"195","author":"R Basu","year":"2007","journal-title":"J Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","article-title":"Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of <italic>Leishmania donovani<\/italic> that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis.","volume":"174","author":"R Basu","year":"2005","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1073\/pnas.0401283101","article-title":"Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen.","volume":"101","author":"C Rollenhagen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1073\/pnas.93.4.1458","article-title":"Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis.","volume":"93","author":"J Hess","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.4049\/jimmunol.163.7.3883","article-title":"TNF receptor p55 is required for elimination of inflammatory cells following control of intracellular pathogens.","volume":"163","author":"ST Kanaly","year":"1999","journal-title":"J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"15551","DOI":"10.1073\/pnas.0505630102","article-title":"The wound repair response controls outcome to cutaneous leishmaniasis.","volume":"102","author":"A Sakthianandeswaren","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(05)59001-8","article-title":"Genes and susceptibility to leishmaniasis.","volume":"59","author":"E Handman","year":"2005","journal-title":"Adv Parasitol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.","volume":"236","author":"CM Snapper","year":"1987","journal-title":"Science"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0165-2478(99)00146-7","article-title":"The humoral immune response to the kinetoplastid membrane protein-11 in patients with American leishmaniasis and Chagas disease: prevalence of IgG subclasses and mapping of epitopes.","volume":"70","author":"C Trujillo","year":"1999","journal-title":"Immunol Lett"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1096\/fj.07-9254com","article-title":"Retooling Leishmania metabolism: from sand fly gut to human macrophage.","volume":"22","author":"D Rosenzweig","year":"2008","journal-title":"FASEB J"},{"key":"ref51","first-page":"423","article-title":"From genomes to vaccines for leishmaniasis.","volume":"270","author":"CB Stober","year":"2004","journal-title":"Methods Mol Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1098\/rstb.2001.0985","article-title":"From genomes to vaccines: Leishmania as a model.","volume":"357","author":"R Almeida","year":"2002","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1128\/IAI.68.3.1328-1336.2000","article-title":"Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants.","volume":"68","author":"T Aebischer","year":"2000","journal-title":"Infect Immun"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0169-4758(99)01473-8","article-title":"Antigen presentation by macrophages harboring intravesicular pathogens.","volume":"15","author":"P Overath","year":"1999","journal-title":"Parasitol Today"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1371\/journal.pone.0000040","article-title":"Mapping the antigenicity of the parasites in <italic>Leishmania donovani<\/italic> infection by proteome serology.","volume":"1","author":"M Forgber","year":"2006","journal-title":"PLoS One"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e8376","DOI":"10.1371\/journal.pone.0008376","article-title":"Proteome-based analysis of serologically defined tumor-associated antigens in cutaneous lymphoma.","volume":"4","author":"M Forgber","year":"2009","journal-title":"PLoS One"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1084\/jem.181.4.1527","article-title":"A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.","volume":"181","author":"YA Skeiky","year":"1995","journal-title":"J Exp Med"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1128\/IAI.00101-06","article-title":"Cloning, characterization, and serodiagnostic evaluation of <italic>Leishmania infantum<\/italic> tandem repeat proteins.","volume":"74","author":"Y Goto","year":"2006","journal-title":"Infect Immun"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1242\/jcs.108.12.3715","article-title":"The role of macrophage receptors in adhesion and uptake of <italic>Leishmania mexicana<\/italic> amastigotes.","volume":"108","author":"C Peters","year":"1995","journal-title":"J Cell Sci"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/eji.200939455","article-title":"Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation.","volume":"40","author":"E Deak","year":"2010","journal-title":"Eur J Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.vaccine.2008.12.053","article-title":"KMP-11 DNA immunization significantly protects against <italic>L. donovani<\/italic> infection but requires exogenous IL-12 as an adjuvant for comparable protection against <italic>L. major<\/italic>.","volume":"27","author":"S Bhaumik","year":"2009","journal-title":"Vaccine"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1016\/j.vaccine.2010.07.063","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis.","volume":"28","author":"E Nascimento","year":"2010","journal-title":"Vaccine"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1016\/j.vaccine.2007.05.010","article-title":"Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis.","volume":"25","author":"J Moreno","year":"2007","journal-title":"Vaccine"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.vaccine.2008.01.026","article-title":"Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f+MPL-SE vaccine to treat canine visceral leishmaniasis.","volume":"26","author":"J Miret","year":"2008","journal-title":"Vaccine"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.vaccine.2009.03.045","article-title":"Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas.","volume":"27","author":"CB Palatnik-de-Sousa","year":"2009","journal-title":"Vaccine"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/icb.2009.31","article-title":"<italic>Salmonella enterica<\/italic> serovar Typhi live vector vaccines finally come of age.","volume":"87","author":"JE Galen","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijmm.2007.07.009","article-title":"A vaccine against <italic>Helicobacter pylori<\/italic>: towards understanding the mechanism of protection.","volume":"298","author":"T Aebischer","year":"2008","journal-title":"Int J Med Microbiol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"e5879","DOI":"10.1371\/journal.pone.0005879","article-title":"Priming of <italic>Salmonella enterica<\/italic> serovar Typhi-specific CD8<sup>+<\/sup> T cells by suicide dendritic cell cross-presentation in humans.","volume":"4","author":"R Salerno-Goncalves","year":"2009","journal-title":"PLoS One"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4161\/hv.7.0.14556","article-title":"Vaccines for Leishmaniasis: From proteome to vaccine candidates.","volume":"7","author":"J Schroeder","year":"2011","journal-title":"Hum Vaccin"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/IAI.68.4.2135-2141.2000","article-title":"Pilot study of phoP\/phoQ-deleted <italic>Salmonella enterica<\/italic> serovar Typhimurium expressing <italic>Helicobacter pylori<\/italic> urease in adult volunteers.","volume":"68","author":"H Angelakopoulos","year":"2000","journal-title":"Infect Immun"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1371\/journal.pntd.0000125","article-title":"An oral recombinant vaccine in dogs against <italic>Echinococcus granulosus<\/italic>, the causative agent of human hydatid disease: a pilot study.","volume":"2","author":"AF Petavy","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0264-410X(01)00516-3","article-title":"Immunogenicity of chi4127 phoP- <italic>Salmonella enterica<\/italic> serovar Typhimurium in dogs.","volume":"20","author":"DS McVey","year":"2002","journal-title":"Vaccine"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0264-410X(00)00197-3","article-title":"<italic>Salmonella typhimurium<\/italic> as a basis for a live oral <italic>Echinococcus granulosus<\/italic> vaccine.","volume":"19","author":"JA Chabalgoity","year":"2000","journal-title":"Vaccine"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T08:48:35Z","timestamp":1686559715000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001406"}},"subtitle":[],"editor":[{"given":"Diane","family":"McMahon-Pratt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,27]]},"references-count":73,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001406","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,27]]}}}